Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs78797390 | chr6:15210373 | A/T | 0.000123 | 131 | 37.53 | 45.93 | NA | KM Plot |
| TGCT | rs78817793 | chr2:29519631 | C/T | 0 | 134 | 43.68 | 24.23 | 0.57 | KM Plot |
| TGCT | rs78826827 | chr2:3487322 | A/G | 2.43E-5 | 131 | 40.57 | 66.17 | 25.32 | KM Plot |
| TGCT | rs78934412 | chr6:28419202 | T/G | 0 | 133 | 46.07 | 25.38 | 0.57 | KM Plot |
| TGCT | rs79045902 | chr7:127147127 | A/G | 1.49E-5 | 134 | 42.1 | 37.53 | 100.87 | KM Plot |
| TGCT | rs7921734 | chr10:8628416 | T/C | 3.88E-7 | 133 | 43.68 | 33.53 | 17.58 | KM Plot |
| TGCT | rs7940103 | chr11:67343157 | T/A | 2.1E-8 | 128 | 41.97 | 105.68 | 20.6 | KM Plot |
| TGCT | rs7943062 | chr11:113817286 | C/T | 8.71E-9 | 134 | 46.3 | 36.12 | 10.52 | KM Plot |
| TGCT | rs79436018 | chr7:127694032 | T/C | 5.66E-5 | 134 | 46.07 | 37.53 | 9.77 | KM Plot |
| TGCT | rs79437914 | chr16:67578143 | C/A | 0 | 133 | 46.07 | 24.1 | 0.57 | KM Plot |
| TGCT | rs7954897 | chr12:107046220 | C/T | 3.53E-8 | 132 | 48.87 | 45.1 | 27.93 | KM Plot |
| TGCT | rs7958469 | chr12:107052620 | G/A | 0.000103 | 134 | 48.87 | 38.2 | 28.8 | KM Plot |
| TGCT | rs7959062 | chr12:107107334 | G/T | 5.07E-5 | 134 | 46.77 | 45.1 | 28.67 | KM Plot |
| TGCT | rs79631436 | chr16:67728369 | T/A | 1.53E-7 | 132 | 45.83 | 22.4 | 73.72 | KM Plot |
| TGCT | rs7966564 | chr12:107142681 | G/A | 3.98E-12 | 134 | 41.97 | 49.93 | 24.27 | KM Plot |